Results
43
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
43 companies
Novartis
Market Cap: CHF 187.0b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 96.58
7D
-4.1%
1Y
-1.5%
Merck
Market Cap: US$202.5b
Operates as a healthcare company worldwide.
MRK
US$81.14
7D
-3.4%
1Y
-31.6%
Waters
Market Cap: US$18.0b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$303.68
7D
3.6%
1Y
-8.9%
Orion Oyj
Market Cap: €9.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€65.65
7D
-0.8%
1Y
39.9%
Abbott India
Market Cap: ₹657.6b
Operates as a pharmaceutical company in India.
500488
₹30,922.70
7D
-0.2%
1Y
10.6%
SK Biopharmaceuticals
Market Cap: ₩8.4t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩108,100.00
7D
-2.2%
1Y
2.2%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹463.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,749.40
7D
-4.0%
1Y
1.9%
Zealand Pharma
Market Cap: DKK 30.4b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 431.10
7D
1.9%
1Y
-51.8%
Xiamen Amoytop Biotech
Market Cap: CN¥32.9b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥79.53
7D
-4.2%
1Y
30.2%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥29.5b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥44.22
7D
-4.8%
1Y
62.1%
HUTCHMED (China)
Market Cap: UK£2.2b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.54
7D
9.0%
1Y
3.7%
Agios Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$36.42
7D
-0.2%
1Y
-23.1%
Neuren Pharmaceuticals
Market Cap: AU$2.5b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$20.14
7D
8.3%
1Y
48.7%
Blue Jet Healthcare
Market Cap: ₹121.1b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹683.30
7D
0.07%
1Y
33.2%
Sanofi India
Market Cap: ₹116.4b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹5,022.70
7D
-1.2%
1Y
-30.1%
CureVac
Market Cap: US$1.2b
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$5.36
7D
-0.4%
1Y
62.9%
L&C BIOLTD
Market Cap: ₩1.5t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩61,200.00
7D
23.9%
1Y
238.9%
Philogen
Market Cap: €907.5m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.
PHIL
€22.50
7D
-3.0%
1Y
11.4%
SIGA Technologies
Market Cap: US$643.7m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.66
7D
-0.7%
1Y
8.7%
Ever Supreme Bio Technology
Market Cap: NT$14.2b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$164.00
7D
0.9%
1Y
-0.9%
GlaxoSmithKline Pakistan
Market Cap: PK₨131.2b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨411.91
7D
1.7%
1Y
140.2%
RPG Life Sciences
Market Cap: ₹39.7b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,394.60
7D
0.2%
1Y
13.4%
CytomX Therapeutics
Market Cap: US$323.2m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$1.93
7D
-6.8%
1Y
62.2%
PharmaEngine
Market Cap: NT$9.3b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$65.90
7D
1.5%
1Y
-23.4%
Abeona Therapeutics
Market Cap: US$291.3m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.64
7D
-13.6%
1Y
3.5%
Puma Biotechnology
Market Cap: US$227.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$4.34
7D
-4.4%
1Y
73.6%
Highnoon Laboratories
Market Cap: PK₨60.3b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,138.77
7D
-1.6%
1Y
65.1%
Coherus Oncology
Market Cap: US$158.1m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.35
7D
3.1%
1Y
28.6%
Hoechst Pakistan
Market Cap: PK₨38.1b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,946.97
7D
-3.7%
1Y
97.3%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft35.1b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,540.00
7D
0%
1Y
5.8%
2invest
Market Cap: €67.3m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€12.20
7D
-1.6%
1Y
14.0%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.5b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م695.39
7D
-0.8%
1Y
203.6%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.4b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م225.43
7D
-1.1%
1Y
205.4%
Winston Medical Supply
Market Cap: NT$2.0b
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.
6817
NT$111.00
7D
0.5%
1Y
17.2%
Fidson Healthcare
Market Cap: ₦98.7b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦43.00
7D
0%
1Y
225.8%
JW Shinyak
Market Cap: ₩79.1b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,507.00
7D
-0.7%
1Y
-1.5%